Biohaven Highlights BHV-1420 at ASN Kidney Week 2026
Biohaven's oral presentation spotlights BHV-1420, a TRAP degrader designed to selectively remove autoantibodies that drive membranous nephropathy.
Biohaven's oral presentation spotlights BHV-1420, a TRAP degrader designed to selectively remove autoantibodies that drive membranous nephropathy.